NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485
Completed · Phase 2
Conditions studied: Parkinson Disease
In brief
The goal of this study is to assess the impact of CoQ10 and GPI 1485 on the progression of Parkinson's disease, in order to determine whether it is reasonable to proceed with further study of either of these agents.
Key facts
- Study ID
- NCT00076492
- Run by
- University of Rochester
- People needed
- 195
- Starts
- 2004-01-01
- Expected to finish
- 2005-09-01
- Last updated by the study team
- 2012-11-02
Who can join
Age: 30 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Rochester Medical Center — Rochester, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.